Position in OCS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,329,017
+$4,051,443 QoQ
Shares Held
2,042,467
+123.7% QoQ
Ownership
3.68%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 59 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCS Over Time
Shares Held
Position Value (USD)
Derivatives in OCS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
140,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,706,513 across 321 Biotechnology names. OCS ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in OCS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 OCSAW | — | 140,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $28,329,017 | 2,042,467 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 OCSAW | — | 140,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $24,277,574 | 913,034 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 OCSAW | — | 140,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $312,350 | 15,641 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 OCSAW | — | 140,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 OCSAW | — | 140,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 OCSAW | — | 140,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 OCSAW | — | 140,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 OCSAW | — | 140,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 OCSAW | — | 140,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 OCSAW | — | 140,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 OCSAW | — | 140,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 OCSAW | — | 140,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 OCSAW | — | 206,666 | Call | Sole | 2023-08-14 | |
| 2023-03-31 OCSAW | — | 206,666 | Call | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||